Ted Rieger received his PhD in Chemical Engineering from Northwestern where he developed models of protein aggregation of Huntington. After graduate school, he joined Entelos, Inc in the Bay Area where he spent 6 years, developing and utilizing Quantitative Systems Pharmacology (QSP) models to understand drug development questions, primarily in the area of cardiometabolic diseases. In 2011, Ted transitioned to Pfizer’s Systems Biology Group in our CVMET Research Unit. He has been at Pfizer since then, and is now a Senior Principal Scientist in the QSP Group in Early Clinical Development. He presently supports programs in the cardiometabolic space from early discovery through proof-of-concept.